Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Patriot Pharmaceuticals is a wholly-owned subsidiary of Johnson & Johnson that specializes in the distribution of authorized generic versions of J&J's proprietary pharmaceutical products. By offering authorized generics, the company provides patients with high-quality, cost-effective alternatives to brand-name medications while ensuring the products are identical in formulation and manufacturing standards to the original brands. Their portfolio includes treatments across several therapeutic areas, including neurology, psychiatry, and urology. Key products distributed by Patriot include authorized generic versions of Concerta, Invega, and Elmiron, leveraging the established safety and efficacy profiles of Janssen's original research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Patriot.